Clinical Trials Logo

Filter by:
NCT ID: NCT05678452 Recruiting - Clinical trials for Benign Prostatic Hyperplasia

Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays. Many settings are used but no optimal setting was world wide adopted. The aim of this trial is to assess the Low-power Holmium laser enucleation of the prostate (LP-HoLEP)and compare to high-power (HP-HoLEP) for enucleation efficiency pertaining to the advantages of lower cost and minimal postoperative dysuria, storage symptoms, and negative sexual impact.

NCT ID: NCT05678413 Recruiting - Stricture Urethra Clinical Trials

Role of Paclitaxel in Stricture Urethra

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Stricture urethra is a common disease and has various causing factors. The most common performed procedure is direct visual internal urethrotomy (DVIU), but unfortunately has a high recurrence rates. Multiple trial were performed to improve the outcomes of DVIU. Various intralesional injections were used. in this trial we will evaluate intralesional paclitaxel injection following DVIU.

NCT ID: NCT05674565 Recruiting - Cerebral Palsy Clinical Trials

Magnesium Sulphate Neuroprotective Strategies for Preterm Deliveries

Start date: January 20, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

A Cochrane systematic review has confirmed that fetal exposure to magnesium sulphate given before preterm birth has a neuroprotective role. This review also showed a significant reduction in the rate of gross motor dysfunction in early childhood. Early Preterm birth (< 34+0 weeks) and very low birthweight (< 1,500 g) are the principal risk factors for cerebral palsy. Multiple pregnancy accounts for over 10% of preterm births and has a higher incidence of cerebral palsy than singleton pregnancy (twins have 7 times and triplets 47 times the risk of cerebral palsy compared with singletons).

NCT ID: NCT05674552 Recruiting - Status Epilepticus Clinical Trials

Exogenous Ketone Esters for Refractory Status Epileptics

EKERSE
Start date: January 10, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to investigate the efficacy of add-on exogenous ketone esters for the treatment of children with refractory generalized convulsive status epilepticus

NCT ID: NCT05674253 Recruiting - Clinical trials for Atrial Fibrillation New Onset

Combined Use of Dexmedetomidine and Hydrocortisone to Prevent New Onset AF After CABG Surgery

Start date: December 25, 2022
Phase: Early Phase 1
Study type: Interventional

Atrial fibrillation (AF) occurs in 20% to 40% of patients after Coronary artery bypass grafting (CABG) and is associated with numerous detrimental sequelae. In postoperative period, the patient may be exposed to several proarrhythmogenic factors as increased endogenous catecholamines, inflammatory and oxidative mediators secondary to surgical stress and the systemic response to cardiopulmonary bypass, use of inotropic support. Steroids suppress the release of the above-mentioned inflammatory mediators. Dexmedetomidine is sympatholytic, along with anti-inflammatory properties. so combined use of both drugs may have synergistic effect to prevent post operative AF (POAF)

NCT ID: NCT05673122 Recruiting - Immediate Implants Clinical Trials

Socket-Shield Technique With Immediate Implant

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Primary Objective: Evaluate of labial plate of bone changes using immediate implant with the socket shield technique in anterior esthetic zone. Secondary Objective: Evaluate of soft tissue changes using the immediate implant with socket shield technique in anterior esthetic zone.

NCT ID: NCT05672784 Recruiting - Postoperative Pain Clinical Trials

Genicular Nerve Block Versus Its Combination With Infiltration Between Popliteal Artery and Capsule of Posterior Knee

Start date: November 5, 2022
Phase: N/A
Study type: Interventional

comparing Genicular Nerve Block with its combination with infiltration Between Popliteal Artery and Capsule of Posterior Knee for Enhanced Recovery After total Knee Arthroplasty

NCT ID: NCT05672056 Recruiting - Clinical trials for Surgery, Computer-Assisted

Novel Application of a Low-cost Alternative to Patient Specific Implants (PSI) in Mandibular Free Fibula Flap Reconstruction by Reverse Engineering of Stock Plates: A Pilot Validation Study

Start date: May 2023
Phase: N/A
Study type: Interventional

Stock reconstruction plates have been used for decades and represent a tried-and-true alternative to custom plating. Stock plates are readily available, are cost effective, and can be accurately bent before surgery, particularly when using stereolithographic models. Unfortunately, the use of stock plates typically precludes the utilization of predictive holes; this can make inset more difficult as the plates do not precisely match the native mandibular contour. Previous descriptions of fabricating predictive holes with stock plates have been inaccurate and inefficient. We aim with conducting this research to improve on the ability of pre-bent stock plates of reproducing the VSP in the operating theater allowing accurate native mandible fixation, accurate fibular segments harvest and accurate inset of the reconstruction in lieu of using the expensive alternative of PSI, thus expanding the use of VSP in mandibular reconstruction in resource limited institutions.

NCT ID: NCT05671497 Recruiting - Clinical trials for Rheumatoid Arthritis

The Effect of Cilostazol on Rheumatoid Arthritis Patients

Start date: November 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of this study is to evaluate the effect of cilostazol on Rheumatoid Arthritis patients. It aims to answer the questions of : 1. Will Cilostazol improve the disease severity and quality of life in Rheumatoid arthritis patients? 2. Will Cilostazol decrease the oxidative stress, inflammation and endothelial dysfunction in Rheumatoid arthritis patients? Participants will be randomized into two arms either treatment or control the treatment group will be asked to take Cilostazol 100 mg twice daily in addition to the usual DMARD (Methotrexate , Sulfasalazine , Hydroxychloroquine or Leflunomide), while the control group will be taking the usual DMARDs only. Patients in both arms will be followed-up every 2 weeks through out the 6-month duration of the study.

NCT ID: NCT05671172 Recruiting - Pain, Postoperative Clinical Trials

Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

Since TAP block needs to affect several nerves in single tissue plane with a single prick, hyaluronidase is expected to aid greatly in the spread of the LA and help the block. However, there have not been adequate studies to establish the efficacy of adding hyaluronidase in lateral TAP after cesarean section. Hence, the present study was carried out to evaluate the efficacy of hyaluronidase in different concentrations added to bupivacaine in US-guided bilateral lateral TAP block.